Discover
TOI
The Oncology Institute, Inc.
5.13
1 x 5.14
1 x 5.20
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 44.10% | |
| 1y | 26.04% |
4.87
day range
5.15
2.32
52 week range
7.05
| Open | 4.93 | Prev Close | 5.13 | Low | 4.87 | High | 5.15 | Mkt Cap | 512.91M |
| Vol | 1.21M | Avg Vol | 1.98M | EPS | -0.36 | P/E | -14.25 | Forward P/E | -1.28 |
| Beta | 0.62 | Short Ratio | 3.38 | Inst. Own | 47.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 5.28 | 200-d Avg | 3.86 | 1yr Est | 2.00 |
| Income Statement | |||
| Total Revenue | 161.28M | ||
| Revenues (USD) | 161.28M | ||
| Cost of Revenue | 134.12M | ||
| Gross Profit | 27.17M | ||
| Operating Expenses | 31.78M | ||
| Selling, General and Administrative Expense | 29.94M | ||
| Operating Income | -4.62M | ||
| Interest Expense | 1.86M | ||
| Net Income | -8.24M | ||
| Net Income Common Stock | -8.24M | ||
| Net Income Common Stock (USD) | -8.24M | ||
| Consolidated Income | -9.79M | ||
| Net Income to Non-Controlling Interests | -1.55M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -6.38M | ||
| Earning Before Interest & Taxes (USD) | -6.38M | ||
| Weighted Average Shares | 103.03M | ||
| Weighted Average Shares Diluted | 103.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.09M | ||
| Cash and Equivalents (USD) | 41.09M | ||
| Trade and Non-Trade Receivables | 66.71M | ||
| Current Assets | 128.99M | ||
| Property, Plant & Equipment Net | 31.77M | ||
| Total Assets | 178.23M | ||
| Debt Current | 7.23M | ||
| Total Debt | 104.48M | ||
| Current Liabilities | 94.94M | ||
| Debt Non-Current | 97.25M | ||
| Total Liabilities | 203.15M | ||
| Accumulated Retained Earnings (Deficit) | -283.70M | ||
| Shareholders Equity | -24.91M | ||
| Shareholders Equity (USD) | -24.91M | ||
| Assets Non-Current | 49.24M | ||
| Total Debt (USD) | 104.48M | ||
| Goodwill and Intangible Assets | 16.82M | ||
| Inventory | 20.01M | ||
| Liabilities Non-Current | 108.21M | ||
| Trade and Non-Trade Payables | 60.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.84M | ||
| Net Cash Flow from Financing | -218.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.81M | ||
| Capital Expenditure | -908.00K | ||
| Issuance (Purchase) of Equity Shares | 90.00K | ||
| Issuance (Repayment) of Debt Securities | -308.00K | ||
| Net Cash Flow from Investing | -908.00K | ||
| Net Cash Flow from Operations | 11.94M | ||
| Share Based Compensation | 1.07M | ||